Cambrex advances $120M US API expansion with Charles City Engineering milestone
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
Subscribe To Our Newsletter & Stay Updated